MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
18.60
-0.26
-1.38%
After Hours: 18.51 -0.09 -0.50% 18:59 12/16 EST
OPEN
19.00
PREV CLOSE
18.86
HIGH
19.70
LOW
18.36
VOLUME
274.63K
TURNOVER
--
52 WEEK HIGH
130.00
52 WEEK LOW
6.76
MARKET CAP
219.04M
P/E (TTM)
-0.9251
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharma Secures Rights to TNX-4900 for Pain Management
TipRanks · 11h ago
Tonix Pharma Announces Licensing Exclusive Worldwide Rights To TNX-4900, Small-Molecule S1R Antagonist With Demonstrated Analgesic Activity In Multiple Models Of Neuropathic Pain
Benzinga · 11h ago
Tonix Pharmaceuticals announces licensing worldwide rights to TNX-4900
TipRanks · 11h ago
TONIX PHARMACEUTICALS ANNOUNCES LICENSING TNX-4900, A SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST FOR CHRONIC NEUROPATHIC PAIN FROM RUTGERS UNIVERSITY
Reuters · 12h ago
Weekly Report: what happened at TNXP last week (1208-1212)?
Weekly Report · 1d ago
Tonix Pharma Appoints New General Counsel
TipRanks · 12/09 12:57
Tonix Pharmaceuticals Names Irina Ishak General Counsel
Reuters · 12/09 12:01
TONIX PHARMACEUTICALS APPOINTS IRINA ISHAK AS GENERAL COUNSEL
Reuters · 12/09 12:00
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.